I assist authors in preparing their full chapter submissions and track important deadlines to ensure they are met. I maintain constant and effective communication with authors, editors, and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing or reviewing. From chapter submission and review to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. We, firmly hope that the knowledge shared in this book would immensely contribute to the global goal of elimination of Papillomavidae and related cancers, and serve as a beacon of “teal light” symbolizing cancer eradication, from the lighthouse of Scientific wisdom and Social welfare, The InTech publishers."Īs an Author Service Manager, my responsibilities include monitoring and facilitating all publishing activities for authors and editors. This book has, well experienced and dedicated scientists from all over the world, contributing chapters in the fields of Epidemiology of HPV HPV Vaccination – Efficacy – acceptance, affordability and policies Pathophysiology and carcinogenesis of HPV Hi-Tech screening protocols, methodologies for HPV testing Diagnosis and treatment of Pre cancers and invasive cancers due to HPV Prevention and control of Papillomaviridae infections and related Cancers of Cervix, Vagina, Vulva, Penis, Anus and Oropharynx. This book “glows in teal”, committing itself, to the noble task of elimination of HPV infections and related cancers. 90% of women identified with cervical disease receive treatment (90% of women with precancer treated, and 90% of women with invasive cancer managed 70% of women are screened with a high-performance test by 35 years and again by 45 yearsģ. 90% of girls fully vaccinated with HPV vaccine by age 15 years.Ģ. The trident strategies of WHO, for meeting these challenges, are the NEXT GEN SOLUTIONS:ġ. Elimination of HPV infections and Cervical Cancer as a Public Health problem, bringing down the Incidence rate of Cervical cancer to below 4 per 100,000, are the NEO CHALLENGES.
All the other elimination and eradication programs were for Infectious Diseases. This is the First time in the History of Global Health, a Cancer is aimed for Elimination. The WHO in 2017, launched a very unique and ambitious program of ""Elimination of Cervical Cancer as a Public Health problem, by 2030"".
About 70% of cancers of the oropharynx may be linked to HPV. In general, HPV is thought to be responsible for more than 90% of anal and cervical cancers, about 70% of vaginal and vulvar cancers, and more than 60% of penile cancers.
HPV AF in women ranges from <3% in Australia/New Zealand and the US to 26% in sub-Saharan Africa. "Globally, 570,000 cases per year in women and 60,000 cases in men are caused by HPV, respectively, 8.6% and 0.8% of all cancers occurring worldwide.